Drinking diet beverages helps people lose weight, a groundbreaking new, multi-center, clinical study to be published in the June issue of Obesity, the journal of The Obesity Society, has confirmed.
The study, the first prospective, randomized clinical trial to directly compare the effects of water and diet beverages on weight loss within a behavioral weight loss program, was conducted simultaneously by researchers at the University of Colorado Anschutz Health and Wellness Center and Temple University's Center for Obesity Research and Education, Philadelphia.
Obesity
Obesity is a condition where there is excess accumulation of body fat which poses a risk to the health of the individual. It can affect children and adults.
Advertisement
Study participants were randomly assigned to one of two groups: those who were allowed to drink diet beverages, such as diet sodas, teas and flavored waters, and those who were in a control group that drank water only. With the exception of beverage options, both groups followed an identical diet and exercise program for the duration of the study.
For more information, to receive a copy of the embargoed study or to connect with researchers, contact Caty Bennett, cbennett@webershandwick.com, (212) 445-8261.
Source: Newswise
Source: Newswise
Childhood Obesity
Childhood obesity is one of the most serious health challenges in the developing countries and needs to be understood and tackled effectively.
Advertisement
 Atkins DietAtkins diet is a low carbohydrate diet and aids in weight loss. It was developed by Robert Atkins. | Advertisement
|
Advertisement
Recommended Readings
Latest Clinical Trials News
Erdafitinib is the first approved FGFR-targeted treatment for advanced urothelial cancer, reveal scientists.
Amyotrophic lateral sclerosis patients' motor neurons responded robustly to Parkinson's drug ropinirole.
A new way to quickly eliminate fungal infections in the mouth has been developed by researchers at Penn Dental and Penn Engineering, using magnetically guided nanorobots.
Researchers tested the effectiveness of virus-mediated gene therapy for genetic hearing loss in an aged mouse model with genetic changes related to deafness.
The outcomes of the first clinical trial demonstrate the safety and efficacy of the measles-rubella (MR) vaccination to adults and infants as young as 9 months.